Unknown

Dataset Information

0

Seeking high-priority mutations enabling successful antibody-breeding: systematic analysis of a mutant that gained over 100-fold enhanced affinity.


ABSTRACT: "Antibody-breeding" has provided therapeutic/diagnostic antibody mutants with greater performance than native antibodies. Typically, random point mutations are introduced into the VH and VL domains of parent antibodies to generate diverse libraries of single-chain Fv fragments (scFvs), from which evolved mutants are selected. We produced an scFv against estradiol-17? with 11 amino acid substitutions and a?>100-fold improved affinity constant (Ka?=?1.19 × 1010?M-1) over the parent scFv, enabling immunoassays with >30-fold higher sensitivity. We systematically analyzed contributions of these substitutions to the affinity enhancement. Comparing various partial scFv revertants based on their Kas indicated that a revertant with four substitutions (VH-L100gQ, VL-I29V, -L36M, -S77G) exhibited somewhat higher affinity (Ka?=?1.46 × 1010?M-1). Finally, the VH-L100gQ substitution, occurring in VH complementarity-determining region (CDR) 3, was found to be the highest-priority for improving the affinity, and VL-I29V and/or VL-L36M cooperated significantly. These findings encouraged us to reconsider the potential of VH-CDR3-targeting mutagenesis, which has been frequently attempted. The substitution(s) wherein might enable a "high rate of return" in terms of selecting mutants with dramatically enhanced affinities. The "high risk" of generating a tremendous excess of "junk mutants" can be overcome with the efficient selection systems that we developed.

SUBMITTER: Oyama H 

PROVIDER: S-EPMC7075871 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Seeking high-priority mutations enabling successful antibody-breeding: systematic analysis of a mutant that gained over 100-fold enhanced affinity.

Oyama Hiroyuki H   Kiguchi Yuki Y   Morita Izumi I   Yamamoto Chika C   Higashi Yuka Y   Taguchi Miku M   Tagawa Tatsuya T   Enami Yuri Y   Takamine Yuriko Y   Hasegawa Hanako H   Takeuchi Atsuko A   Kobayashi Norihiro N  

Scientific reports 20200316 1


"Antibody-breeding" has provided therapeutic/diagnostic antibody mutants with greater performance than native antibodies. Typically, random point mutations are introduced into the V<sub>H</sub> and V<sub>L</sub> domains of parent antibodies to generate diverse libraries of single-chain Fv fragments (scFvs), from which evolved mutants are selected. We produced an scFv against estradiol-17β with 11 amino acid substitutions and a >100-fold improved affinity constant (K<sub>a</sub> = 1.19 × 10<sup>1  ...[more]

Similar Datasets

| S-EPMC2696811 | biostudies-literature
| S-EPMC7511398 | biostudies-literature
| S-EPMC3209665 | biostudies-literature
| S-EPMC1434743 | biostudies-literature
| S-EPMC7473582 | biostudies-literature
| S-EPMC5790052 | biostudies-literature
| S-EPMC4934459 | biostudies-literature
| S-EPMC3615484 | biostudies-literature
| S-EPMC9562432 | biostudies-literature
| S-EPMC6538933 | biostudies-literature